sitem-insel AG

sitem-Insel School in a Nutshell

sitem-insel – the Swiss Institute for Translational and Entrepreneurial Medicine in Bern – has been created to establish, operate and develop a National Center of Excellence for Translational Medicine. Translational medicine is a new, process-oriented discipline that aims to translate new findings and products emerging from private-sector development and basic research into clinical applications.

A major criticism of the current translation process is the lack of professionalization. Therefore, the sitem-insel School aims to promote researchers and train executives in the fields of translational medicine and biomedical entrepreneurship. Lecturers and supervisors of the
school are representatives from research and development-oriented private companies, scientists from universities, clinicians, collaborators from regulatory agencies and financial experts.

Participants are expected to acquire the necessary skills to initiate and implement the translation process from the stage of development in industrial or basic science institutions into clinical applications with the ultimate purpose of the latters’ commercialization. The acquired theoretical knowledge can be applied to the participants’ own projects in order to provide possible strategies to each individual project.

The program is organized by the Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel AG) and approved by the University of Bern - participants may obtain the degrees of «Master of Advanced Studies» (MAS), «Diploma of Advanced Studies» (DAS) or «Certificate of Advanced Studies» (CAS).

Upon successful completion of the curriculum a Certificate of Advanced Studies (CAS), a Diploma of Advanced Studies (DAS) or a Master of Advanced Studies (MAS) is awarded by the University of Berne. The CAS and the DAS can be performed alongside the usual professional work (part-time).

The MAS is a two-year lasting full-time program, consisting of a master thesis focusing on a real, practical translational project (80%) and theory (20%). The master thesis will be supervised and judged by a partner from a private-sector company and an academic clinician. The theoretical knowledge acquired during the 6 modules will be directly and specifically applied to the project, according to the “learning by doing” concept. In the master thesis presented at completion of the MAS, participants are expected to present a mature project from both a translational and entrepreneurial aspect.